The livers of the T2DM rats showed significantly higher mRNA levels of SREBP1, FAS, and ACC-1 and lower mRNA levels of PPARα and CPT1 as compared to those of the control and control + SFFE-treated rats (Figure 5A–E). This evidence concerns the gene FAS and type 2 diabetes mellitus.